Philip Morris International Inc. (PM), headquartered in Stamford, Connecticut, is a leading global tobacco company dedicated ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...

Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...

Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

The Massachusetts Court of Appeals upheld a $5 million jury verdict against Philip Morris in a former smoker’s lawsuit ...